Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (527)	11/5/2001 8:46:45 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 555

<<Since the AHA late breaker status was acknowledged at BC before results would have been known, I'm not sure late breaker status necessarily means a positive outcome. Maybe you scientists would know better.>> Not a scientist. :( Late breaker is for clinical trial results, that did not meet abstract deadline. None is written about results. However, I do not think that someone will continue with late breaker presentation if trial failed. In CVTX case the question is how good are results, and are they in line with investors expectation (whatever is their expected)?